End-stage Renal Disease
Every 1 mg/dL increase in serum phosphorus was independently associated with a 36% increased relative risk of kidney failure.
Recently, increasing attention focused on mineralocorticoid receptor antagonists (MRAs) in treating chronic kidney disease (CKD).
Strenuous aerobic activities found to decrease the risk of ESRD by 42% compared with no physical activity.
Study shows that 59% of men with end-stage renal disease were on hemodialysis versus 41% of women.
But targeting an HbA1c level below 6.5% is associated with a decreased risk of end-stage renal disease.
Large study looked at matched pairs of lupus patients with renal disease starting dialysis with hemodialysis or peritoneal dialysis.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
One hospitalization for associated with a 4.9-fold increased risk of end-stage renal disease.
Study reveals circadian variation in phosphate, parathyroid hormone, and 25-hydroxyvitamin D levels in patients with end-stage renal disease.
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
Investigators used a novel algorithm to characterize this rare and often life-threatening disorder seen mostly in ESRD patients.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Proteinuria, hypertension, and obesity in adolescence independently predict development of end-stage renal disease.
The finding is from a study of more than 5 million Norwegians.
Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.
Would any heterogeneity in the choice of additional services be unethical or implausible?
It is associated with better long-term survival and reduced risk of revascularization and myocardial infarction compared with PCI.
Distinguishing primary from secondary focal segmental glomerulosclerosis is crucial because the treatment approaches and therapeutic goals differ.
They also are at elevated risk of cardiovascular and all-cause mortality, study finds.
Hepatitis C virus infection increases CKD patients' likelihood of progressing to end-stage renal disease by 32%.
Heart failure, myocardial infarction, or stroke also increase the risk of death prior to ESRD.
If renal replacement therapy planning were started only when patients reached CKD stage 5, many patients would not be adequately prepared, researchers said.
In a study, hemodialysis patients with more than 14 decayed, missing, or filled teeth had a 67% increased risk of death.
Poor dental health, but not periodontal disease, is an independent risk factor for ESRD.
A nearly 5-fold higher risk of Clostridium difficile infection observed in patients with end-stage renal disease requiring dialysis.
Dialysis is not necessarily in the patient's best interest, clinicians and ethicists say.
Expertscape gives the no. 1 spot to Kamyar Kalantar-Zadeh, MD, MPH, PhD.
Use is associated with fewer hospitalizations versus sevelamer carbonate and calcium acetate.
Study reveals an association with greater use of ESAs and higher inpatient and outpatient costs.
Researchers observed reduced phosphorus levels in HD patients whose diet restricted intake of phosphorus additives.
Sign Up for Free e-newsletters
- Optimal PSA Threshold For Targeted Biopsy Identified
- Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients
- Testosterone Replacement Therapy (TRT) Beneficial in Diabetes Mellitus Patients
- Stopping Renal Cell Carcinoma (mRCC) Drugs Induces Tumor Flare
- Red Meat Contributes to Cardiovascular Disease (CVD) Risk Due to Gut Bacteria
- Once Pregnant, Living Kidney Donors More Likely to Have Hypertension
- Have malpractice award caps made any difference in medical practice?
- Erectile Dysfunction (ED) Linked to Early Vascular Disease
- Cost of Diabetes Care Continues to Rise
- 'Jekyll & Hyde' Molecule Could Lead to Aggressive Prostate Cancer (PCa)
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)